Please select the option that best describes you:

What is your approach to deciding on whether or not to start anticoagulation in patients with an elevated CHADSVASc score and atrial fibrillation with co-existing cerebral amyloid angiopathy?   

Or would you opt to refer to EP for Watchman consideration?